Literature DB >> 10927627

Effects of infantile thymectomy on ovarian functions and gonadotrophin-induced ovulation in prepubertal mice: role of thymulin.

L García1, L Hinojosa, R Domínguez, R Chavira, P Rosas.   

Abstract

The effects of thymectomy performed on 10-day-old (Tx-10) mice on spontaneous puberty and the ovulatory response induced by gonadotrophin treatment were analysed, together with the effects of thymulin replacement from 10 days of age. Infantile thymectomy induced a delay of puberty, a decrease in serum 17beta-oestradiol concentration and a reduced total number of follicles. Injection of thymulin (12 ng/g body weight) to Tx-10 mice resulted in an earlier onset of puberty, a decrease in the weights of ovaries and uterus, and an increase in serum 17beta-oestradiol concentrations. In control and Tx-10 mice, treatment with pregnant mare serum gonadotrophin (PMSG) (5 IU) at 25 days of age resulted in ovulation and the numbers of ova shed by ovulating animals were similar. When the animals were injected with 1 IU PMSG ovulation did not occur. In Tx-10 mice, both 1 and 5 IU PMSG increased the number of follicles to values similar to those observed in the controls. In Tx-10 mice the sequential injection of PMSG (1 IU) and human chorionic gonadotrophin (hCG) (3 IU) resulted in ovulation, but the number of ova shed was lower than in controls. When these animals were injected daily with thymulin, an increase in the number of ova shed and serum 17beta-oestradiol concentrations was observed. The uterine weight of Tx-10 mice was always significantly reduced in response to gonadotrophin treatment. Thymulin injection in PMSG-hCG-treated Tx-10 mice provoked a significant increase in uterine weight. The results suggest that the presence of the thymus after the neonatal period is necessary to normal ovarian development and function. The increase in gonadotrophin-induced ovarian response produced by thymulin replacement indicates that this peptide has a role in this process as one of the connecting signals between thymus and ovaries.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10927627     DOI: 10.1677/joe.0.1660381

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Thymulin-based gene therapy and pituitary function in animal models of aging.

Authors:  Paula C Reggiani; Brenda Poch; Gloria M Cónsole; Omar J Rimoldi; Jose I Schwerdt; Victoria Tüngler; Margarita M Garcia-Bravo; Mireille Dardenne; Rodolfo G Goya
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

2.  Neonatal thymulin gene therapy prevents ovarian dysgenesis and attenuates reproductive derangements in nude female mice.

Authors:  Paula C Reggiani; Claudio G Barbeito; Gustavo O Zuccolilli; Gloria M Cónsole; Alicia M Flamini; Mireille Dardenne; Rodolfo G Goya
Journal:  Endocrinology       Date:  2012-06-14       Impact factor: 4.736

Review 3.  The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin.

Authors:  Paula C Reggiani; Gustavo R Morel; Gloria M Cónsole; Claudio G Barbeito; Silvia S Rodriguez; Oscar A Brown; Maria Jose Bellini; Jean-Marie Pléau; Mireille Dardenne; Rodolfo G Goya
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

4.  Morphological restoration of gonadotrope population by thymulin gene therapy in nude mice.

Authors:  P Reggiani; E Martines; C Ferese; R Goya; G Cónsole
Journal:  Histol Histopathol       Date:  2009-06       Impact factor: 2.303

5.  Tissue-specific mouse mRNA isoform networks.

Authors:  Gaurav Kandoi; Julie A Dickerson
Journal:  Sci Rep       Date:  2019-09-27       Impact factor: 4.379

6.  Effect of thymectomy on the female reproductive cycle in neonatal guinea pigs.

Authors:  P Murali; J Radhika; D Alwin
Journal:  Clin Exp Reprod Med       Date:  2020-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.